CIK 0000899923
- Accelerated filer
MYRIAD GENETICS INC
Sign in to watch- Ticker
- MYGN
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 870494517
- Phone
- +1 801-584-3600
- Business address
- 322 NORTH 2200 WEST, SALT LAKE CITY, UT, 84116
- Former names
- MYRIAD GENETICS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $34,252
- in 1 filing
Net −$34,252. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2016-12-01 | HENDERSON JOHN T Director | Grant or award | +15,024 | 36,524 | ||
| 2016-12-01 | BEST LAWRENCE C Director | Grant or award | +15,024 | 32,524 | ||
| 2016-10-17 | Riggsbee Richard Bryan Chief Financial Officer | Returned to the company | −3,522 | $19.31 | $68K | 66,152 |
| 2016-09-30 | Wenstrup Richard Chief Medical Officer | Returned to the company | −931 | $20.58 | $19K | 50,207 |
| 2016-09-30 | Ford Alexander President, MGL | Returned to the company | −1,937 | $20.58 | $40K | 29,213 |
| 2016-09-30 | Tobin Bernard President Crescendo BioScience | Returned to the company | −4,661 | $20.58 | $96K | 118,991 |
| 2016-09-30 | Riggsbee Richard Bryan Chief Financial Officer | Returned to the company | −5,599 | $20.58 | $115K | 69,674 |
| 2016-09-30 | McDade Ralph L President Myriad RBM, Inc. | Returned to the company | −1,641 | $20.58 | $34K | 82,891 |
| 2016-09-30 | King Gary A. Exec. VP International Ops | Returned to the company | −4,050 | $20.58 | $83K | 103,449 |
| 2016-09-30 | Capone Mark Christopher President & C.E.O. | Returned to the company | −9,238 | $20.58 | $190K | 207,451 |
| 2016-09-30 | LANCHBURY JERRY S Chief Scientific Officer | Returned to the company | −5,459 | $20.58 | $112K | 107,034 |
| 2016-09-30 | MARSH RICHARD M E.V.P., General Counsel | Returned to the company | −3,646 | $20.58 | $75K | 110,134 |
| 2016-09-17 | Wenstrup Richard Chief Medical Officer | Returned to the company | −931 | $20.92 | $19K | 51,138 |
| 2016-09-17 | Ford Alexander President, MGL | Returned to the company | −1,335 | $20.92 | $28K | 31,150 |
| 2016-09-17 | McDade Ralph L President Myriad RBM, Inc. | Returned to the company | −2,188 | $20.92 | $46K | 84,532 |
| 2016-09-17 | King Gary A. Exec. VP International Ops | Returned to the company | −3,721 | $20.92 | $78K | 107,499 |
| 2016-09-17 | Capone Mark Christopher President & C.E.O. | Returned to the company | −8,042 | $20.92 | $168K | 216,689 |
| 2016-09-17 | LANCHBURY JERRY S Chief Scientific Officer | Returned to the company | −4,752 | $20.92 | $99K | 112,493 |
| 2016-09-17 | MARSH RICHARD M E.V.P., General Counsel | Returned to the company | −4,606 | $20.92 | $96K | 113,780 |
| 2016-09-14 | Wenstrup Richard Chief Medical Officer | Grant or award | +30,000 | 52,069 |
Page 48 of 60 · 1,194 trades